Re: Additional Exempt Distribution

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

KOO-KOO2

Rank: Treasurer [?]

Points: 10765 [?]

Votes: 39 Score: 2.3 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Additional Exempt Distribution

in response to

Re: Additional Exempt Distribution

richaard

posted on Dec 04, 2023 11:45AM

Part of the transaction includes 5 million share purchase warrants that can be exchanged for common shares before the exercise date as noted, at 82 cents (US).

Koo

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply